Cancer Biomarkers and Oncoviruses

著者名：Ennaji PhD., Moulay Mustapha (EDT)

Academic Press（2025/12/11発売）

• 言語：ENG
• ISBN：9780443302251
• eISBN：9780443302268

Description

Cancer Biomarkers and Oncoviruses examines the extensive clinical applications of biomarkers in cancer research, with a particular focus on oncoviruses. The book explores key topics such as cancer risk assessment, screening, and early detection. It further covers accurate diagnosis, patient prognosis, prediction of response to therapy, and cancer surveillance and monitoring. In 47 detailed chapters, Cancer Biomarkers and Oncoviruses presents the molecular biology and pathogenesis of viral oncology, the mechanisms of viral oncogenesis in humans, signaling pathways, and therapeutic options such as vaccines. It also discusses the future of cancer therapy involving oncoviruses.The present book also covers critical analyses of cost savings in healthcare, respiratory biomarkers in viral infections, and lessons learned from the COVID-19 pandemic, focusing on pandemic preparedness, early detection, surveillance, and response strategies. These discussions aim to provide valuable insights into how lessons from the pandemic can be applied to improve healthcare systems and response strategies for both viral infections and cancer, helping inform future health management practices.This book is an invaluable resource for health professionals, scientists, researchers, health practitioners, students, and anyone seeking to deepen their understanding in the field of cancer and virology. It offers valuable state-of-the-art insights, incorporating the latest research and cutting-edge developments in the field.- Provides current, systematic scientific information on oncoviruses, including the molecular characteristics of cancers associated with these viruses, along with recent diagnostic and treatment strategies, and future perspectives in the field- Addresses key topics in tumor science by offering a comprehensive overview of cancers, covering diagnosis, cellular mechanisms, and therapeutic approaches- Incorporates critical analyses and lessons learned from the COVID-19 pandemic, focusing on pandemic preparedness, early detection, surveillance, and response strategies, providing insights that can be applied to cancer research and healthcare management- Offers up-to-date and comprehensive information to support informed decision-making regarding cancer diagnosis, treatment, and research, while also helping to shape future healthcare practices

Table of Contents

Part 1 Cancers: genetic insights, molecular mechanisms, and emerging therapiesChapter 1: Breast cancer and new methods for treatmentChapter 2: The role of genetic markers P53, BRCA1, and BRCA2 in breast cancer risk assessment in womenChapter 3: MicroRNAs as key regulators of hormone dependent pathways in breast cancerPart 2 Lung and prostate cancer: genetic abnormalities and biomarkersChapter 4: Genetic abnormalities of the EGFR pathway in the Middle East and North African patients with non-small cell lung cancerChapter 5: MicroRNAs: advances in biomarkers, diagnostics, and therapeutic strategies in prostate cancerPart 3 HPV and cervical cancer: screening, prevention, and molecular mechanismsChapter 6: Human papillomavirus infections in cervical cells for cervical cancer screeningChapter 7: MicroRNA and human herpesvirus 8 oncovirus in prostate cancerPart 4 Vitamin D and immune modulation in cancerChapter 8: Prostate cancer antigen 3 as a diagnostic, prognostic, and therapeutic biomarker in prostate cancerChapter 9: Interaction of the vitamin D in cancer development and progressionPart 5 Emerging therapies and biomarkers in cancerChapter 10: Study of the role of microRNAs in epstein barr virus induced prostate carcinogenesisChapter 11: Addressing the burden of human papillomavirus-related cancers in North Africa: epidemiology, sociocultural barriers and prevention strategiesPart 6 Management of the COVID-19 pandemic: lessons learned, surveillance, and respiratory biomarkers in SARS-CoV-2 pathogenesisChapter 12: Management of the COVID-19 pandemic in Skhirate-Temara, Morocco: lessons in preparedness, surveillance, and rapid responseChapter 13: Respiratory biomarkers in the pathogenesis of SARS-CoV-2Part 7 Viral miRNAs and oncoviruses: diagnostic, prognostic biomarkers, and therapeutic implications in cancerChapter 14: Oncoviruses and cancer biomarkers: current and future perspectivesChapter 15: MicroRNAs in cancer development: biomarkers, functions and therapyChapter 16: Viral miRNA's: unlocking new frontiers in virus-induced cancersPart 8 Genetic and molecular basis of cancerChapter 17: Molecular alterations involved in lung cancerChapter 18: Oncogenic BRAF in prostate cancer: exosomes and miRNA status and implications for targeted therapyChapter 19: Targeted therapy in prostate and bladder cancer—role of BRAF and RAS mutationsChapter 20: In-depth analysis of tumor markers in leukemiaPart 9 Molecular mechanisms and therapeutic implications in cancerChapter 21: Nasopharyngeal cancer associated with epstein barr virusChapter 22: Molecular mechanisms of cervical cancerPart 10 Economic and market analysis in cancer researchChapter 23: Critical analysis of the cost savings generated by biomarkers and oncoviruses in healthcareChapter 24: Market analysis of exosome technologies for the diagnosis of genitourinary cancersPart 11 Phage therapy and immune modulationChapter 25: Phagotherapy: The discreet power of our immune cellsPart 12 Emerging therapies and biomarkers in cancerChapter 26: Mechanism of resistance to platinum salt-based chemotherapyChapter 27: Marine algae as a source of bioactive compounds: unlocking anticancer potentialChapter 28: Cervical cancer: new treatment approaches using microRNAChapter 29: Therapeutic potential of the intratumoral microbiota in tumorsChapter 30: Molecular biomarkers in bladder cancer: identification and clinical relevanceChapter 31: Emerging biomarker applications for precision targeting in bladder cancer therapyChapter 32: Fusion gene and cancerChapter 33: Immunotherapy biomarkers in melanoma: fromprogrammed death-ligand 1 expression to tumor mutational burdenChapter 34: The role of vitamin D supplementation in cancer treatmentChapter 35: The role of vitamin D in modulating immune responses against oncoviruses human papillomavirus, Epstein–Barr virus, and human herpesvirus-8Part 13 Epigenetics and DNA methylation in cancerChapter 36: Post-transcriptional epigenetic marks: DNA and microRNA